When and How to Use Reversal Agents for Direct Oral Anticoagulants?

被引：0
|
作者：
Antonio Gómez-Outes
Mª Luisa Suárez-Gea
Ramón Lecumberri
机构：
[1] Agencia Española de Medicamentos y Productos Sanitarios (AEMPS),Division of Pharmacology and Clinical Drug Evaluation
[2] University Clinic of Navarra,Hematology Service
[3] Instituto de Salud Carlos III,Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV)
来源：
Current Cardiology Reports | 2023年 / 25卷
关键词：
Idarucizumab; Andexanet alfa; Prothrombin complex concentrates; Ciraparantag; VMX-C001; Anticoagulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：371 / 380
页数：9
相关论文
共 50 条
  • [41] Reversal strategies in patients treated with direct oral anticoagulants
    Gressenberger, Paul
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2019, 48 (05) : 389 - 392
  • [42] Latest advances in the reversal strategies for direct oral anticoagulants
    Escal, Jean
    Lanoiselee, Julien
    Poenou, Geraldine
    Zufferey, Paul
    Laporte, Silvy
    Mismetti, Patrick
    Delavenne, Xavier
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (04) : 674 - 684
  • [43] Engineering Reversal - Finding an Antidote for Direct Oral Anticoagulants
    Hunt, Beverley J.
    Levi, Marcel
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (12): : 1185 - 1186
  • [44] Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on reversal agents
    Di Fusco, Stefania Angela
    Luca, Fabiana
    Benvenuto, Manuela
    Iorio, Annamaria
    Fiscella, Damiana
    D'Ascenzo, Fabrizio
    Madeo, Andrea
    Colivicchi, Furio
    Di Lenarda, Andrea
    Gulizia, Michele Massimo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 75 - 79
  • [45] The use of Gastroprotective Agents in Patients with Atrial Fibrillation Initiating Direct Oral Anticoagulants
    Chobanov, Jan
    Man, Kenneth K. C.
    Wong, Ian Chi Kei
    Lau, Wallis
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 237 - 237
  • [46] Use of New Oral Anticoagulants/Direct Oral Anticoagulants in Malignant Patients
    Khan, Yusra
    Zaidi, Syed Owais
    Razak, Bibi S.
    Zaki, Mariann
    Malik, Bilal Haider
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
  • [47] Direct oral anticoagulants for use in paediatrics
    Jaffray, Julie
    Young, Guy
    LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (03): : 207 - 214
  • [48] Novel oral anticoagulants and reversal agents: Considerations for clinical development
    Sarich, Troy C.
    Seltzer, Jonathan H.
    Berkowitz, Scott D.
    Costin, James
    Curnutte, John T.
    Gibson, C. Michael
    Hoffman, Maureane
    Kaminskas, Edvardas
    Krucoff, Mitchell W.
    Levy, Jerrold H.
    Mintz, Paul D.
    Reilly, Paul A.
    Sager, Philip T.
    Singer, Daniel E.
    Stockbridge, Norman
    Weitz, Jeffrey I.
    Kowey, Peter R.
    AMERICAN HEART JOURNAL, 2015, 169 (06) : 751 - 757
  • [49] Direct oral Anticoagulants How safe are they really?
    Stollberger, Claudia
    Pommer, Peter
    Schneider, Birke
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (19) : 1410 - 1411
  • [50] Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal
    Samos, Matej
    Stanciakova, Lucia
    Skornova, Ingrid
    Bolek, Tomas
    Kovar, Frantisek
    Stasko, Jan
    Galajda, Peter
    Mokan, Marian
    Kubisz, Peter
    CURRENT DRUG METABOLISM, 2017, 18 (07) : 643 - 650
12345